Skip to main content
. 2021 Mar 12;43(3):359–364. doi: 10.1590/2175-8239-JBN-2020-0225

Table 4. Clinical and laboratory data for ckd patients with or without cardiovascular disease.

  CKD Group 1 Patients (n=25) CKD Group 2 +CVD Patients (n=25) p-value
IL-10 (pg/mL) 5.68±10.12 26.01± 81.29 0.55
IL-13 (pg/mL) 5.82± 12.63 2.69±4.65 0.44
IL-8 (pg/mL) 498.24±446.51 638.72±524.67 0.39
TGF-β1(pg/mL) 65.95±150.69 53.91±151.22 0.49

Values are expressed by mean ± SD. Group 1: CKD patients without cardiovascular disease. Group 2: CKD patients with cardiovascular disease. TGF-β1: transforming grow factor -β1, IL-8: interleukin-8, IL-10: interleukin-10, IL-13: interleukin-13.